Skip to content
HowShorted

CAPRICOR THERAPEUTICS, INC. short interest in 2024

In 2024, CAPRICOR THERAPEUTICS, INC.'s disclosed short interest ran from 8.75% of shares outstanding on 12 Jan 2024 to 17.49% on 31 Dec 2024, a change of +8.74 percentage points. The year's high was 23.13% on 13 Sep 2024 and its low 8.46% on 15 Nov 2024, averaging 14.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.95 days on 13 Sep 2024. Full history: CAPRICOR THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CAPRICOR THERAPEUTICS, INC. in 2024

2024 in figures

Start of year
8.75% (12 Jan 2024)
End of year
17.49% (31 Dec 2024)
Change
+8.74 pp
High
23.13% (13 Sep 2024)
Low
8.46% (15 Nov 2024)
Average
14.31%
Highest days to cover
45.95 (13 Sep 2024)
SEC filings marked
9

Every report in 2024

CAPRICOR THERAPEUTICS, INC. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20248.75%9.01
31 Jan 20248.73%14.16
15 Feb 20248.69%18.74
29 Feb 20248.77%13.38results (8-K)
15 Mar 202410.29%8.7310-K filed
28 Mar 202411.15%7.31
15 Apr 202411.43%14.19
30 Apr 202413.19%8.36
15 May 202413.41%16.50results (8-K), 10-Q filed
31 May 202414.54%10.81
14 Jun 202414.38%12.90
28 Jun 202414.89%5.97
15 Jul 202418.68%13.67
31 Jul 202419.76%22.77
15 Aug 202421.50%16.97results (8-K), 10-Q filed
30 Aug 202422.96%29.74
13 Sep 202423.13%45.95
30 Sep 202416.10%1.00
15 Oct 202419.00%1.20
31 Oct 202416.23%2.75results (8-K)
15 Nov 20248.46%3.49results (8-K), 10-Q filed
29 Nov 20249.70%3.85
13 Dec 202412.30%2.85
31 Dec 202417.49%5.98

See also: CAPRICOR THERAPEUTICS, INC.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.